INSMED: PLANS TO INITIATE PHASE 3 TRIAL IN PATIENTS WITH PH-ILD BEFORE END OF 2025 AND PHASE 3 TRIAL IN PATIENTS WITH PAH IN EARLY 2026

Reuters · 06/10 11:00

Please log in to view news